Has Tiberio Lindgren received payments from drug or device companies?

Yes. Drug and device makers reported $13,576 in general payments to Tiberio Lindgren across 806 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Tiberio Lindgren did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Tiberio Lindgren come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Tiberio Lindgren

Hematology & Oncology · Orange, CANPI 1275585424

Payments from drug & device makers

$13,576in general payments, 2019–2025

Across 806 payments — averaging $16.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Amgen$1K
AstraZeneca$1K
E.r. Squibb & Sons, L.L.C.$939
Seagen Inc.$714
Novartis$705
Exelixis Inc.$588
plus $8K from 54 others

What the payments were for

Food & beverage$13,38599%
Education$1901%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Amgen	69	$1,271
AstraZeneca(2 entities)	59	$1,246
E.r. Squibb & Sons, L.L.C.	91	$939
Seagen Inc.	43	$714
Novartis	39	$705
Exelixis Inc.	22	$588
Pharmacyclics LLC, An Abbvie Company	33	$574
Merck	33	$559
Genentech USA, Inc.	33	$547
Bristol Myers Squibb	31	$486
Eisai Inc.	22	$377
Pfizer	45	$365
Myovant Sciences Inc.	20	$328
AbbVie	17	$286
Johnson & Johnson(2 entities)	16	$278
Bayer	16	$269
Array Biopharma Inc	14	$224
Gilead(2 entities)	13	$208
Regeneron Healthcare Solutions, Inc.	7	$206
GSK	13	$197
Incyte Corporation	11	$193
Puma Biotechnology, Inc.	10	$188
Beigene USA, Inc.	8	$181
Aurobindo Pharma USA, Inc.	2	$180
Astellas Pharma US Inc	9	$174
Takeda Pharmaceuticals U.S.A., Inc.	10	$168
Foundation Medicine, Inc.	8	$147
AMAG Pharmaceuticals, Inc.	6	$147
Sanofi	9	$146
Daiichi Sankyo Inc.	7	$143
EMD Serono, Inc.	8	$142
Coherus Oncology, Inc.	8	$135
Karyopharm Therapeutics Inc.	6	$108
Epizyme, Inc.	5	$75
Blueprint Medicines Corporation	3	$71
Acceleron Pharma, Inc.	3	$68
Pharmacosmos Therapeutics Inc.	4	$66
Dova Pharmaceuticals	4	$66
AVEO Pharmaceuticals, Inc.	3	$64
Deciphera Pharmaceuticals Inc.	3	$55
Clovis Oncology, Inc.	4	$51
Jazz Pharmaceuticals Inc.	2	$50
Rigel Pharmaceuticals, Inc.	3	$49
Tersera Therapeutics LLC	3	$49
Servier Pharmaceuticals LLC	2	$44
EUSA Pharma (US) LLC	3	$40
CSL Behring	2	$35
Sobi, Inc	2	$28
Macrogenics, Inc.	1	$26
Teva Pharmaceuticals USA, Inc.	2	$26
Mylan Institutional Inc.	1	$25
Acrotech Biopharma Inc.	1	$24
Boehringer Ingelheim	2	$24
Blue Earth Diagnostics	1	$21
Alnylam Pharmaceuticals Inc.	1	$19
Spectrum Pharmaceuticals Inc.	1	$18
Stemline Therapeutics Inc.	1	$18
Taiho Oncology, Inc.	1	$18
Tesaro, Inc.	1	$16
Emmaus Medical, Inc.	1	$16

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$13,576 in reported general payments places this provider in the 55th percentile of 1,363 hematology & oncology providers in California.

See all hematology & oncology providers in California →

Other hematology & oncology in Orange

Nataliya MarOrange$10.4M
Deepa JeyakumarOrange$10.4M
Arash Rezazadeh KalebastyOrange$8.7M
Misako NagasakaOrange$7.4M
Sai Hong OuOrange$6.8M
Catherine CoombsOrange$4.9M
Ritesh ParajuliOrange$3.7M
Alain AlgaziSan Francisco$119.2M
David BerzLos Angeles$43.3M
Jonathan GoldmanSanta Monica$35.7M

See the full list for California →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →